Welcome to the Emerging Pathogens & Infectious Diseases Consortium
Welcome to EPIC – the Emerging Pathogens and Infectious Diseases Consortium.
EPIC brings together researchers, clinicians, and institutions across the University of Toronto and its hospital partners to advance infectious disease research and build lasting resilience against emerging threats.
This work builds on a long legacy: EPIC partners have played an integral role in infectious disease research for a century, from work that helped control diphtheria and eradicate smallpox, to today’s front-line research in antimicrobial resistance and infection control. Our collective response to COVID-19, highly pathogenic avian influenza, and mpox makes clear there’s never been a more important time to advance that work, from emerging pathogens and antimicrobial resistance to health inequities and public trust.
Building on this momentum, EPIC marshals the advanced research infrastructure and world-renowned research and training expertise of our EPIC partners to deliver an integrated, innovative response to the infectious disease challenges facing communities today and in the future.
Seven EPIC research clusters
Antimicrobial Resistance
Protecting the effectiveness of the medicines we depend on.
Chronic Infections
Addressing the long-term burden of infections that don’t resolve.
Emerging Pathogens
Detecting and responding to new and re-emerging threats before they spread.
Health Inequities
Ensuring infectious disease research and response reach everyone, equitably.
Health Systems Resilience
Building health systems that bend, not break, under infectious threats.
Misinformation, Disinformation & Public Trust
Strengthening public trust through clear, credible information.
Sepsis & Acute Respiratory Distress
Improving detection and treatment when every minute counts.
EPIC News
U of T-developed livestock vaccine for deadly bacterial disease advances toward use in Africa and South Asia
From left: Scott Gray-Owen, Jamie Fegan, Epshita Islam and Trevor Moraes (Photo: Rulin Yuan) 14 April 2026 By Betty Zou A vaccine developed by Emerging & Pandemic Infections Consortium (EPIC) researchers at University of Toronto is one step closer to market with...
EPIC celebrates four PhD graduates advancing infectious disease research as 2026 Future Leaders
From left: Krithika Muthuraman, Salma Sheikh-Mohamed, Alison Simmons and Maxine Ty 13 April 2026 By Betty Zou Four University of Toronto graduates are being recognized with the 2026 Future Leaders Prize from the Emerging and Pandemic Infections Consortium. The $5,000...
The Krause Lab investigates diet-microbiota-host interactions to find better treatments for Inflammatory Bowel Disease
Henry Krause and Jaibao 9 April 2026 By Kira Belaoussoff This article was originally published on the Donnelly Centre for Cellular and Biomolecular Research News website. The Krause Lab at the Donnelly Centre has discovered a new potential treatment avenue for...
